Chemomab Therapeutics Ltd. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-19: Form 6-K; Period of report 2026-06-30; Description 6-K; Document zk2635899.htm.
- 2026-07-08: Form 6-K; Period of report 2026-07-08; Description 6-K; Document zk2635653.htm.
- 2026-06-02: Form 6-K; Period of report 2026-06-02; Description 6-K; Document zk2635468.htm.
- 2026-05-14: Form 6-K; Period of report 2026-05-14; Description 6-K; Document zk2635329.htm.